EDGAR Filing Documents for 0001193125-23-041600

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-23-041600

Filing Date

2023-02-17

Accepted

2023-02-17 08:59:15

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d721068ds3.htm	S-3	408919
2	EX-1.2	d721068dex12.htm	EX-1.2	211331
3	EX-4.1	d721068dex41.htm	EX-4.1	341346
4	EX-4.2	d721068dex42.htm	EX-4.2	335195
5	EX-4.3	d721068dex43.htm	EX-4.3	33584
6	EX-4.4	d721068dex44.htm	EX-4.4	33077
7	EX-5.1	d721068dex51.htm	EX-5.1	30472
8	EX-23.1	d721068dex231.htm	EX-23.1	2191
9	EX-FILING FEES	d721068dexfilingfees.htm	EX-FILING FEES	51169
10	GRAPHIC	g721068dsp207.jpg	GRAPHIC	3894
11	GRAPHIC	g721068dsp207a.jpg	GRAPHIC	15876
12	GRAPHIC	g721068g80a01.jpg	GRAPHIC	43195
	Complete submission text file	0001193125-23-041600.txt		1529439

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459

Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600

Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)